| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |